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Abstract
A system based on high-performance affinity chromatography was developed for characterizing the binding,
elution and regeneration kinetics of immobilized antibodies and immunoaffinity supports. This information
was provided by using a combination of frontal analysis, split-peak analysis and peak decay analysis to determine the rate constants for antibody–antigen interactions under typical sample application and elution conditions. This technique was tested using immunoaffinity supports that contained monoclonal antibodies for
2,4-dichlorophenoxyacetic acid (2,4-D). Association equilibrium constants measured by frontal analysis for
2,4-D and related compounds with the immobilized antibodies were 1.7–12 × 106 M−1 at pH 7.0 and 25 °C. Splitpeak analysis gave association rate constants of 1.4–12 × 105 M−1 s−1 and calculated dissociation rate constants of
0.01–0.4 s−1 under the application conditions. Elution at pH 2.5 for the analytes from the antibodies was examined by peak decay analysis and gave dissociation rate constants of 0.056–0.17 s−1. A comparison of frontal analysis results after various periods of column regeneration allowed the rate of antibody regeneration to be examined, with the results giving a first-order regeneration rate constant of 2.4 × 10−4 s−1. This combined approach
and the information it provides should be useful in the design and optimization of immunoaffinity chromatography and other analytical methods that employ immobilized antibodies. The methods described are not limited to the particular analytes and antibodies employed in this study but should be useful in characterizing
other targets, ligands and supports.
Keywords: biointeraction analysis, immunoaffinity chromatography, high-performance affinity chromatography, split-peak analysis, peak decay analysis, frontal affinity chromatography, antibody–antigen interactions,
kinetic studies

analytes to an immobilized ligand because it is easiest to monitor the changes in signal under such conditions. An alternative approach that could be used to examine the binding of antibodies to a small target would be to immobilize the target
and use soluble antibodies. However, this gives a system that
may have different mass transfer properties and immobilization effects than a system that uses an immobilized antibody
support [26–28], which could lead to errors when applying the
results of thermodynamic or kinetic measurements from one
system to the other.
This current report explores an alternative approach for examining the binding of analytes to immobilized antibodies by
using high-performance affinity chromatography (HPAC).
Like SPR, it is known that affinity chromatography can be used
to obtain both kinetic and thermodynamic information on a solute–ligand interaction, but this is now accomplished by looking at the changes in elution profile of an analyte as it passes
through a support containing the immobilized ligand [32–37].
Because this approach uses a post-column device to detect the
analyte, there are no limitations on the type of support that can
be examined; it is possible to utilize this method with the same
type of material and immobilized ligand that will be used in

1. Introduction
The use of immobilized antibodies is popular in analytical techniques such as enzyme-linked immunosorbent assays
(ELISAs), immunosensors, chromatographic immunoassays,
and immunoaffinity chromatography [1–9]. The ability of an
antibody to recognize a specific target and bind this with high
affinity gives these methods good selectivity and low limits of
detection [7–14]. In addition, the use of immobilized antibody
supports in combination with other methods (e.g., reversedphase chromatography) has seen growing use in environmental and biological applications as a means for extracting and
concentrating a given group of analytes from complex samples [8, 9, 15–22].
The design and optimization of these techniques requires
information on how the immobilized antibodies will bind and
dissociate from their target compounds. Surface plasmon resonance (SPR) is one approach for obtaining equilibrium and
rate constants for the binding of antibodies to these targets
[23–31]; however, this method does have limitations. One limitation is that this method is restricted to materials that have
appropriate optical properties for SPR measurements. In addition, SPR tends to work best for studying the binding of large
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the analytical method being optimized or developed. In addition, it is possible in this chromatographic approach to use a
wide range of detectors (e.g., UV–vis, fluorescence, and mass
spectrometry). This allows the detection of smaller analytes
than in SPR and makes it easier to study the interactions of
small molecules with immobilized ligands [35, 37].
This work will consider the development and use of an integrated approach based on affinity chromatography for examining immobilized antibody supports. The approach will
be tested and illustrated by using antibodies against 2,4-dichlorophenoxyacetic acid (2,4-D) and related herbicides as a
model. Items to be evaluated will include the association equilibrium constants and binding capacity of the immobilized antibodies, as well as their association and dissociation rate constants under sample application conditions. The dissociation
rates of retained analytes under the column elution conditions
will also be examined along with the rate of regeneration for
the immobilized antibodies after sample elution. The theory
behind these measurements will be discussed, and a few examples will be given that show how this information can be
used to predict the performance of an immobilized antibody
support when it is later employed for immunoaffinity chromatography and compound analysis.
2. Methods
2.1. Reagents
The E2/G2 monoclonal anti-2,4-D antibodies were provided
by the Vet Research Center (Brno, Czech Republic) [38]. Nucleosil Si-1000 (7 μm particle diameter, 1000 Å pore size) was
obtained from P.J. Cobert (St. Louis, MO, USA). The 2,4-D;
2,4-dichlorophenoxyacetate methyl ester (2,4-D-Me); 2,4,5-trichlorophenoxyacetic acid (2,4,5-T); 4-chloro-2-methylphenoxyacetic acid (MCPA); and 4-chlorophenoxyacetic acid (4-CPA)
were from Sigma–Aldrich (St. Louis, MO, USA). Reagents for
the micro bicinchoninic acid (BCA) protein assay were from
Pierce (Rockford, IL, USA). All solutions were prepared with
water from a Nanopure system (Barnstead, Dubuque, IA, USA).
All other reagents were of the highest grades available.
2.2. Apparatus
The chromatographic system consisted of ten-port and sixport Rheodyne LabPro electronically actuated valves from
Alltech (Deerfield, IL, USA) along with three MicroStar pumps
and one K-2500 UV–vis detector from Sonntek (Upper Saddle River, NJ, USA). Data acquisition was performed using
an SCB-68 NI shielded interface and 16E series PCMCIA card
from National Instruments (Austin, TX, USA). Data were collected using a Gateway Solo 2500 laptop computer (Poway,
CA, USA) and analyzed with a spreadsheet prepared using
Microsoft Excel (Microsoft, Redmond, WA, USA) (see Reference 39 for details on the spreadsheet).
The diol-bonded silica used in antibody immobilization was
prepared from Nucleosil Si-1000 according to previous methods [40]. The coverage of diol groups on this support was found
by an iodometric capillary electrophoresis assay [41] to be 38
(±7) μmol diol/g silica (±1 SD). The E2/G2 monoclonal anti-2,4D antibodies were immobilized onto this support by the Schiff
base method [42], with the immobilization being carried out at
4 °C for three days. The antibodies were added to the silica in a
slurry at a ratio of 1 mg protein/50 mg silica in a total volume of
approximately 5 mL. After this immobilization had been completed, the resulting antibody silica was washed several times
with pH 7.0, 0.1 M potassium phosphate buffer and stored in
this buffer at 4 °C until use. A small portion of the antibody silica was dried under vacuum at room temperature and assayed
for its protein content by a micro BCA protein assay, with re-
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agent grade rabbit IgG (Sigma–Aldrich) being used as the standard. The protein coverage, as determined in triplicate by this
method, was 15.9 (±0.2) mg antibody/g silica.
The antibody silica was packed into a 1 cm × 2.1 mm i.d.
column according to a previous method [43] using a pressure of 3000 psi applied for 30 min and pH 7.0, 0.1 M potassium phosphate buffer as the packing solution. A column of
equal length and diameter was packed by the same technique
with Nucleosil that had been processed in a similar manner to
the antibody silica but without the addition of any antibodies.
This control column was used to correct for non-specific binding of analytes to the support.
2.3. Chromatographic studies
The samples contained 0–100 ng/L of the desired analyte
in the application buffer (pH 7.0, 0.1 M potassium phosphate
buffer). The elution buffer later passed through the antibody
column was typically pH 2.5, 0.1 M potassium phosphate buffer, but buffers with pH values of 2.5–5 were also examined.
The elution of 2,4-D and all other analytes was monitored at
223 nm. All the chromatographic studies were performed at
room temperature (22–25 °C). All time values used in the kinetic measurements were corrected for the void time of the
system, which was approximately 0.3 min at 0.4 mL/min.
Each study began by continuously applying a sample of
the analyte onto both the control column and antibody column
under identical flow rate and temperature conditions. These
columns were originally equilibrated for 15 min in the application buffer before coming into contact with the analyte. Subsequent equilibration times were varied to measure the effects
of regeneration time on the antibody column. After this equilibration period, the sample was continuously applied to the
column until a breakthrough curve with a well-defined plateau was obtained. This typically required 5 min at a flow rate
of 0.4 mL/min for applied solutions of 2,4-D or the other analytes; however, at lower flow rates or more dilute analyte concentrations longer times were allowed for this step as needed.
The application flow rate was varied from 0.2 mL/min to
0.75 mL/min during these studies, with each set of studies
being performed in duplicate or triplicate. The overall breakthrough curves that were produced through this process were
then analyzed to determine the binding capacities and association constants for the interaction of the analyte with the immobilized antibodies (see Section 3.2). The overall shape of these
same curves, particularly in the early stages of analyte application, was used to also provide information on the rate of analyte adsorption to the immobilized antibodies (see Section 3.3).
Analyte release from the antibody column was accomplished by passing an appropriate elution buffer through the
system. This caused the retained analytes to dissociate from the
immobilized antibodies and leave the column. A background
peak resulted during this step due to the change in buffer composition. To correct for this peak, the response obtained under
the same conditions for the control column was subtracted from
that for the antibody column. The background corrected results
were then used to examine the dissociation kinetics of each analyte from the immobilized antibody column in the presence
of the given elution buffer (see Section 3.4). The elution buffer was typically passed through these columns for 3 min at
0.5 mL/min; however, other studies were performed in which
the elution buffer had a flow rate of 0.2–0.5 mL/min and passed
through the column for 2–5 min. The results under each set of
conditions were measured at each of the concentrations used in
the frontal analysis work, as described previously, and through
the use of at least duplicate or triplicate studies.
Column regeneration was performed by reapplying the
original application buffer to the column after the elution step.
Frontal analysis was then used to see how the measured bind-

Kinetic

167

s t u d i e s o f i mm o b i l i z e d a n t i b o d i e s

ing capacity of the antibody column changed for 2,4-D as a
function of the regeneration time. This work was performed
using various regeneration times (1.0–5.0 min) and flow rates
(0.5–1.5 mL/min) for washing the antibody column with pH
7.0, 0.1 M potassium phosphate buffer before beginning the
application of analyte. After data from all of these steps had
been acquired, this information was placed into a Microsoft
Excel spreadsheet for data analysis and the determination of
binding capacities, equilibrium constants, and rate constants,
as discussed later in Section 3.
3. Results and discussion
3.1. General analysis scheme
The reaction scheme used in this study to characterize the
immobilized antibodies is shown in Figure 1. This model is
based on the on/off elution scheme that is commonly used
in affinity chromatography for the separation and analysis
of targets with strong binding to an immobilized antibody
or affinity ligand [7, 14]. A typical example of such a scheme
for the immobilized antibodies that were investigated in this
study is shown in Figure 2. The first step in this scheme is to
apply the analyte (A) to the ligand (L) and wash away nonretained components with an application buffer. The second
step involves dissociation and elution of the retained analyte
in the presence of an elution buffer. Due to the large association constants that are present for most antibodies at a physiological pH, this dissociation step generally requires the use
of a pH step change or the addition of a modifier to alter interactions between the analyte and antibody [7, 14, 29]. The
ligand is allowed to regenerate during the third step. It is
during this step that an application buffer/regeneration solution is reapplied to the column, allowing the immobilized ligand to return to its initial conformation before the next sample application [7, 14].
In SPR, the association and dissociation events for analyte–
ligand systems are typically examined only during the application step in Figures 1 and 2 (i.e., under reaction conditions
at or near physiological conditions). The elution and regeneration steps are generally ignored in SPR during quantitative
measurements and are only performed as part of the clean-up
process for the sensor [29, 31] (note: dissociation kinetics can
be examined by SPR when washing the surface with a buffer
containing no analyte [31, 36] and have in some cases been examined in the presence of a different elution buffer [44]). In
this current study, kinetic information generated by HPAC
during both elution and regeneration was also considered as a
means to provide a more complete description of the behavior
of a given analyte and immobilized ligand. The overall process that was used in this report will be demonstrated in the
following sections, in which the information obtained during
sample application, elution and column regeneration will each
be examined in turn during the characterization of an immunoaffinity support.
3.2. Degree of analyte retention during application
The interactions that occurred during the first step in Figures 1 and 2 (sample application) were examined by using
frontal analysis (i.e., frontal affinity chromatography). In this
method, a known concentration of the analyte [A] is applied
to the column at a fixed flow rate while the amount of analyte exiting from the column is monitored. As the column becomes saturated, this process results in a breakthrough curve
in which the mean position of this curve is related to the binding capacity of the column. For monoclonal antibodies or ligands with single-site binding, this data can be examined using the following equation [35],

Figure 1. General kinetic processes used in this study to model the
binding and elution of an analyte in affinity chromatography. In this
model, kA and kD are the association and dissociation rate constants
for analyte–antibody interactions during sample application, kD* is the
first-order dissociation rate constant describing analyte elution, and kR
is the first-order rate constant that describes the regeneration of the
immobilized antibodies.

Figure 2. A typical chromatogram obtained in this study for the examination of analyte binding and elution from an immunoaffinity column. The lighter line shows a chromatographic performed on a control column containing no antibodies, while the heavier line gives the
results obtained for analytes on an immobilized antibody support.

1
1
=
+ 1
(mL,app)
(mLKA[A]) mL

(1)

where KA is the association equilibrium constant for the binding of A to the immobilized ligand, mL,app is the apparent
moles of analyte required to reach the mean position of the resulting breakthrough curve at a given concentration of applied
analyte [A], and mL is the total mole of binding sites in the column for A. Equation (1) indicates that a plot of 1/(mL,app) versus 1/[A] for a homogeneous system with 1:1 binding should
give a straight line with a slope equal to 1/(mLKA) and an intercept equal to 1/(mL). The binding capacity can then be obtained by taking the reciprocal of the intercept, and an estimate of the association equilibrium constant can be obtained
by dividing the intercept by the slope.
Equation (1) works well for ligands with weak-to-moderate
affinities but can also be used for high affinity ligands if measurable dissociation is present, thus allowing the creation of a
local equilibrium at the mean point of the breakthrough curve.
For antibodies, typical association constants are often in the
range of 105–1012 M−1. Equation (1) is particularly useful for
monoclonal antibodies, which tend to have association equilibrium constants at the lower end of this range (KA < 109 M−1);
however, even with higher affinity ligands the intercept of
Equation (1) can be used to provide an estimate of the total
binding capacity for an affinity column.
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Figure 3. Analysis of the association equilibrium constants for several
compounds as they were bound by immunoaffinity columns containing immobilized anti-2,4-D antibodies. These data were analyzed according to Equation (1) for 2,4-D (◊), 2,4-D-Me (□), 2,4,5-T (∆), 4-CPA
(○), and MCPA (*), giving correlation coefficients of 0.96, 0.86, 0.98,
0.99 and 0.93, respectively. Each of the data points shown in this plot
is the average for duplicate or triplicate measurements. Part of the difference in the intercepts of these particular plots (e.g., the 2,4-D results
versus 2,4-D-Me) is a result of loss of some activity over time for the
immunoaffinity columns.

Figure 3 shows some typical plots that were obtained in
this study when the mean positions of frontal analysis curves
for anti-2,4-antibody supports were analyzed according to
Equation (1) [35]. As shown in this figure, plots of 1/mL,app
versus 1/[A] were found to give reasonably good agreement
with a linear fit for the various analytes that were tested under
the application conditions used in this study. The slopes and
intercepts of these plots were then used with Equation (1) to
obtain the total binding capacity (mL) and association equilibrium constant (KA) of the immobilized antibodies for each of
the applied analytes.
The original binding capacity obtained for 2,4-D on this
antibody column was 7.7 (±1.4) × 10−10 mol. Statistically
equivalent or similar values ranging from 7 × 10−10 mol to
12 × 10−10 mol were obtained for the related analytes that were
tested (i.e., 2,4-D-Me; 2,4,5-T; 4-CPA; and MCPA). Based on
the measured protein content of the support in this column
(15.9 mg antibody/g silica) and the known packing density of
the support (0.45 g/cm3), the total antibody content of this column was estimated to be 3.4 × 10−9 mol. This meant that 34–
49% of these antibodies retained their activity for binding to
2,4-D and related compounds after immobilization, as based
on a 1:1 binding model.
The linear behavior noted for the plots in Figure 3 indicated
that Equation (1) could be used to obtain the association equilibrium constants for the anti-2,4-D column with each of the
tested analytes. Using this approach, it was found for the five
related but distinct compounds examined in this study that
the resulting association equilibrium constants ranged from
1.7 × 106 M−1 to 12 × 106 M−1 under the application conditions,
as summarized in Table 1. The differences in these values indicate that slightly different interactions are occurring between
each of these compounds and the immobilized anti-2,4-D
Table 1. Association equilibrium constants and association/dissociation
rate constants of anti-2,4-D monoclonal antibodies at pH 7.0 and 25 °Ca.
Analyte

KA (×106 M−1)

2,4-D
MCPA
2,4,5-T
2,4-D-Me
4-CPA

12.0 (±1.0)
11.8 (±2.7)
3.4 (±0.5)
2.4 (±0.8)
1.7 (±0.3)

a

kA (×105 M−1 s−1)
3.4 (±0.7)
1.4 (±0.5)
12.0 (±2.0)
4.1 (±0.8)
2.6 (±0.7)

kD (s−1)
0.028 (±0.006)
0.012 (±0.005)
0.36 (±0.08)
0.17 (±0.07)
0.15 (±0.05)

The values for KA, kA, and kD were calculated as described in text.
The numbers shown in parentheses represent a range of ±1 SD.
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column; however, this overall range of values is typical of
what would be expected for monoclonal antibodies and are
well within the range of equilibrium constants that are amenable to measurement by frontal analysis. The result of 12.0
(±1.0) × 106 M−1 obtained for 2,4-D is comparable, although not
statistically identical, to previous measurements performed
with the same antibodies using a quartz crystal microbalance,
in which 2,4-D was found to have an association constant of
5.75 × 106 M−1 in the presence of pH 7.0, 0.05 M phosphate buffer [38]. The approximately two-fold difference in these latter
values may have been due to differences in the particular solution and measurement conditions or in the immobilization
methods that were used in these two studies [7].
It was possible from the measured binding capacities and
association equilibrium constants to estimate the retention factor (k) for each analyte on the immunoaffinity support under
the application conditions. This value was calculated by using the relationship k = (KAmL)/VM, where VM is the void volume of the column. Using an average initial binding capacity
of 8 × 10−10 mol gave a retention factor at pH 7.0 and 25 °C that
was greater than 330 for 2,4-D and MCPA and retention factors
that were between roughly 50 and 100 for the other analytes.
The results for 2,4-D and MCPA represented reasonably strong
retention. For instance, at 0.5 mL/min a small plug of 2,4-D or
MCPA would require at least 18–20 min to pass through the immunoaffinity column under the application conditions. This result indicated that the given anti-2,4-D antibody columns could
be successfully used to extract and retain 2,4-D and MCPA from
samples. The other tested analytes would have retention times
ranging from 2.8 min (4-CPA) to 5.5 min (2,4,5-T) under the
same conditions. Careful control of the application and wash
step could also allow the anti-2,4-D antibody column to be used
for the immunoextraction of these agents, as has been demonstrated in recent simulations of immunoaffinity/reversed-phase
systems [22] and in past work examining the binding of anti-atrazine immunoaffinity columns for triazine herbicides and their
degradation products [10, 21].
3.3. Kinetics of analyte retention
The association and dissociation kinetics of each analyte
during the application step were also examined in this study.
If the support is an efficient material with relatively fast mass
transfer from the bulk solution to the surface or interior of the
support, the rate of capture of the analyte during application
process can be modeled by using an adsorption-limited process [35, 37]. The situation occurs when the rate of binding is
limited by the association of the molecule to the antibody. This
type of reaction has been successfully used in the past to describe the adsorption of analytes to HPLC-based immunoaffinity supports (e.g., see Reference [32]). This process is described
in Figure 1 by a second-order adsorption rate constant (kA)
and a first-order dissociation rate constant (kD).
One way in which the rate of this binding can be measured
is by measuring the fraction f of the analyte that is non-retained or “free” at various flow rates [32–34, 37, 45–46]. Under
adsorption-limited conditions and in the case where the rate of
analyte dissociation is slow and negligible versus analyte adsorption, this free and non-retained fraction can be related to
the flow rate (F), association rate constant, number of active
binding sites in the column, and amount of applied analyte, as
shown in Equation (2) [32].
f=

{ LoadS A } ln [1 + e
o

LoadA/So

– 1) e–1/So ]

(2)

In this equation, the term So is equal to F/(kAmL) and Load A
is the ratio of the moles of applied analyte compared to the
moles of binding sites in the column, where Load A = (mol
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Figure 4. Fit between the experimental results and those predicted by
Equation (2) for the application of a 100 ppb solution of 2,4,5-T to an immobilized anti-2,4-D antibody column. The values of both f and Load
A are unitless, as indicated by the definitions of these terms in the text.

A)/mL. Using Equation (2), non-linear application conditions
can be used to calculate the value of kA for an immobilized antibody if the flow rate, amount of applied sample and binding capacity of the column are known. Equation (2) can also
be used to estimate the binding capacity of the column, but in
this study the binding capacity was instead obtained by using
Equation (1), as described in the previous section, to reduce
the number of variables that are present during the measurement of kA (note: alternative kinetic methods based on fitting a
frontal analysis profile are also available, as discussed in References 37 and 47–49).
As shown in Figure 4, a good fit was found for all analytes
between Equation (2) and the early part of a frontal analysis
curve for the immunoaffinity column (i.e., conditions under
which analyte dissociation was essentially negligible; similar
behavior has been seen for the methods described in References
37 and 47–49). The best fit in this response occurred between
Load A values of 0–2. The average deviations over this range
between the predicted and experimental free fraction curves, as
generated according to Equation (2), varied from 1.9% to 16%
for the various analytes that were examined in this report. The
association rate constants determined from these curves (see Table 1) varied from 1.4 × 105 M−1 s−1 to 12 × 105 M−1 s−1 for binding of the immobilized 2,4-D antibodies to the targets examined
in this work. The dissociation rate constants under the application conditions were then calculated by using both these measured association rate constants and the KA values determined
in the previous section, as given by the relationship KA = kA/kD.
These dissociation rate constants are also listed in Table 1 and
ranged from 0.012 s−1 to 0.36 s−1.
A previous report using a piezoelectric quartz crystal microbalance (QCM) gave an association rate constant of 4.5
(±0.3) × 103 M−1 s−1 in the binding of 2,4-D to the same antibodies as used in this report but using immobilized 2,4-D and soluble antibodies [38]. However, it was found in this current study
that using immobilized antibodies and soluble 2,4-D gave an association rate constant of 3.4 (±0.7) × 105 M−1 s−1. This can be explained based on the fact that the rate of antibody binding tends
to be diffusion-limited. In the case of the piezoelectric QCM, diffusion would have been much slower since a large biomolecule
(i.e., an antibody) had to diffuse to the sensor surface before it
could bind to the immobilized 2,4-D. However, in this current
study a faster rate of binding would have been expected since a
small target (2,4-D) was now diffusing to a surface which contained the immobilized antibodies. This difference indicates the
importance of using the same support material and immobilized agent in such kinetic studies as will be used in the final desired application of such substances.

Figure 5. First-order kinetic plots prepared according to Equation (5) for
the elution of several analytes from immobilized anti-2,4-antibodies in
the presence of pH 2.5, 0.10 M phosphate buffer. The “response” used
in the logarithmic term on the y-axis was determined by using the absorbance measurements obtained for the elution profile after subtracting the elution profile for the same analyte from the blank column.

3.4. Kinetics of analyte elution
The rate of release of a retained analyte during elution (i.e.,
Step 2 in Figure 1) was also considered in this work. The rate
of release for an analyte from a high affinity ligand (e.g., an
antibody) when using a step gradient can be described as a
first-order process,
kD

*

A – L*  A* + L*
kA*

(3)

where L*, A*, and A–L* represent the ligand, analyte, and analyte–ligand complex in the presence of the elution buffer, and
kD* and kA* are the dissociation and association rate constants
for the A–L* under these conditions. If A* is removed quickly
from the column during elution and not allowed to rebind to
the immobilized ligand, the association of A* with L* can be ignored in the above reaction. The remaining dissociation process can then be described by the following first-order rate law
and integrated rate expression [37, 50–52],
–d[A – L*] d[A*]
=
= kD* [A*]
dt
dt

(4)

ln[A*] = −kD* t + ln[A*]0

(5)

where t is the time allowed for elution and [A*]0 is the amount
of A* initially present in the system. According to Equation (5),
a plot of ln[A*] versus t should be linear during elution with a
slope equal to −kD*, the dissociation rate constant. Linearization of the signal versus time has been used to determine the
rate constants of many systems [50–55], and is adequate for
calculating the dissociation rate constant for a system based on
a simple bimolecular interaction such as the release of analyte
from the antibody used in this model system [37, 50–52].
The results obtained for 2,4-D and related herbicides are
shown in Figure 5. This elution was found to give a good fit
with a first-order decay process with effective dissociation rate
constants of 0.06–0.176 s−1 being obtained for the given analytes in the presence of pH 2.5, 0.10 M phosphate buffer. Although a good fit was noted between these elution profiles
and the first-order model, there was a decrease of (20–50%)
noted in these apparent dissociation rate constants when the
flow rate was decreased below 0.4–0.5 ml/min. This is believed to be due to a greater chance of reentry of the analytes
in the pores of the support at low flow rates. It was also possible with this method to examine how the dissociation rate
constant changed with elution pH. This result is summarized
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Figure 6. Change in the measured dissociation rate constant with pH
for the elution of 2,4-D from an immunoaffinity column containing
anti-2,4-D-antibodies. Each of the data points shown in this plot is the
average for duplicate or triplicate measurements.

in Figure 6, where much faster elution was noted for 2,4-D as
well as all related compounds from the anti-2,4-D antibodies
as a change was made from a neutral to acidic elution pH.
These dissociation rate constants were also used to calculate the amount of time required to recover a given fraction of
an applied analyte from the immunoaffinity column. For instance, when the anti-2,4-D antibody column is saturated, the
initial amount of 2,4-D on the column is approximately equal
to the binding capacity, or 2.4 × 10−10 mol. If the dissociation
rate constant of the antibody column for 2,4-D is 0.145 s−1 under the given elution conditions (e.g., pH 2.5), 90% of the 2,4-D
will be recovered within 15.8 s. A recovery of 95% or 99% will
take 20.7 s or 31.8 s, respectively. These results indicate that
elution of essentially all the 2,4-D will take place in less than
1 min. The 2,4-D-Me would require elution over 28.8 s, 37.5 s
or 57.6 s for 90%, 95% or 99% recovery; for 2,4,5-T the times
required to obtain the same recoveries would be 24.5 s, 31.9 s
and 49.0 s. This information is helpful in ensuring that a high
degree of each analyte has been dissociated from the immunoaffinity support. A high recovery during elution is desirable
to increase the signal that is obtained for each analyte and to
minimize carryover effects when the immunoaffinity support
is to be used over many sample injections.
3.5. Kinetics of column regeneration
The rate of regeneration for antibodies is another important
issue to consider if the same support is to be used for multiple assays. In this study, the rate of regeneration was examined by plotting the measured binding capacity of the column
after regeneration versus the time allowed for regeneration of
the column. Regeneration of antibodies after dissociation of
analyte has occurred in the presence of an elution buffer may
require the reformation of intra-molecular bonds. This regeneration is typically accomplished by returning the immunoaffinity support to its initial application buffer. It is important to
determine the amount of time and/or solvent that is needed to
return the antibody to its original conformation during the regeneration step because the rate of this process can affect both
the speed with which an assay can be conducted by immunoaffinity chromatography and the practical lifetime of an immunoaffinity support.
Regeneration of an immunoaffinity support was modeled
in this work by using the following first-order reaction,
kR

L*  L
k–R

(6)

where L* is the immobilized ligand in the dissociation state
and L is the immobilized ligand in the binding state (see Figure

in
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Figure 7. Determination of the rate of regeneration for the immobilized anti-2,4-D antibodies in going from pH 2.5, 0.10 M phosphate
buffer to pH 7.0, 0.1 M phosphate buffer at a flow rate of 0.5 mL/min.
Each of the data points shown in this plot is the average for duplicate
or triplicate measurements.

1). As a first-order kinetic process, the regeneration rate that
would be expected for this reaction is described by Equation (7).
–d[L*] d[L]
(7)
dt = dt = kR[L*] + k–R[L]
Assuming that the rate of the back reaction is negligible, the
last term in Equation (7) goes to zero and the rate law becomes
–d[L*]
= kR[L*]
dt

or

–d(mol L*)
= kR (mol L*)
dt

(8)

which can be integrated to give the expressions in Equation
(9).
ln[L*] = −kR t + ln[L*]0 or ln(mol L*) = −kR t + ln(mol L*)0 (9)
This result indicates that a plot of −ln[L*] or −ln(mol L*) versus
regeneration time will provide a straight line with a slope of −
kR and an intercept of ln[L*]0 or ln(mol L*)0 if antibody regeneration follows a first-order process.
The results that were obtained when this model was used
to examine the experimental data are shown in Figure 7. It was
found that a reasonable linear fit to Equation (9) was obtained,
giving a correlation coefficient of 0.995. From this fit, the rate
constant for antibody regeneration was determined to be 2.4
(±0.3) × 10−4 s−1. It was determined from this result that 95% of
the binding sites in the column were regenerated in less than
1 min when using a step change from a pH 2.5 elution buffer
to a pH 7.0 application buffer. This information could be valuable in designing an immunoaffinity system that is to be used
over a large number of sequential injection, elution and regeneration cycles. The intercept of Figure 7 made it possible to estimate the initial amount of active binding sites that must have
been present prior to regeneration with the anti-2,4-D antibody column. This estimated value was 6.3 (±0.1) × 10−10 mol,
which was comparable to the original binding capacity of
7–12 × 10−10 mol that was measured for the same immunoaffinity support by frontal analysis (see Section 3.2).
4. Conclusions
It was found in this study that the direct use of affinity
chromatography is an effective and inexpensive method for
determining equilibrium and rate constants for the binding of
small molecules to monoclonal antibodies. This allowed information to be obtained on the application, elution and regeneration kinetics of immobilized antibodies. This technique was
tested using HPLC supports containing monoclonal antibodies for 2,4-D. Association equilibrium constants measured for
2,4-D and related compounds were 1.7–12 × 106 M−1 at pH 7.0
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and 25 °C, with association and dissociation rate constants of
1.4–12 × 105 M−1 s−1 and 0.01–0.4 s−1. Release of analytes from
these antibodies at pH 2.5 followed a first-order decay model,
with dissociation rate constants of 0.056–0.17 s−1. Regeneration
of the immobilized antibodies also followed a first-order process, with a regeneration rate constant of 2.4 × 10−4 s−1.
It was shown how the information that was obtained in this
study can be useful in the design and optimization of analysis methods employing immobilized antibodies. For instance,
the binding capacities and association equilibrium constants
determined by frontal analysis can be used to determine the
overall degree of retention for an analyte under the sample application conditions. Association rate constants can be used to
determine the rate of analyte extraction, and dissociation rate
constants can be used to predict the rate of analyte release under a given set of elution conditions. The extent of column regeneration can also be optimized by this approach.
The methods described in this study are not limited to the
given analytes and antibodies but should also be useful in kinetic studies with other types of targets, ligands and supports.
This approach allows all aspects of the sample application,
elution and regeneration cycle to be examined for an immunoaffinity support. It should also be possible to use this approach with a wider variety of support materials and surfaces
than can be currently examined by SPR. In addition, this chromatographic approach to kinetic studies can be adapted for
use with a variety of detectors (i.e., as has already been demonstrated for immunoaffinity chromatography in general) [7,
8, 14], making it easier to use than SPR with dilute analytes or
those that do not produce a large change in signal as they bind
to the surface of an SPR sensor. All of these features make this
approach an attractive alternative to SPR for the direct characterization of immunoaffinity materials and for kinetic studies
of immobilized biological molecules.
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